SenesTech highlights Q2 revenue up 56% to $770K in rodent birth control investor deck
SNES•Q2 revenue and margin improved
- Q2 2026 revenue reached $770K, up 56% quarter-on-quarter, with gross margin of 73.6%.
- E-commerce revenue rose to $511K, up 186% quarter-on-quarter, led by Amazon revenue of $349K, up 473%.
- Direct-to-consumer subscription revenue increased to $104K, up 89% quarter-on-quarter, representing 13.5% of quarterly revenue.
Commercial rebuild centers on Evolve and ContraPest
SenesTech outlined its commercial rebuild around rodent birth control products Evolve and ContraPest, shifting toward a revenue-driven, data-led model.
Management cited market opportunity and effectiveness data
Management highlighted a $1.8 billion to $2.0 billion U.S. market within a $4.5 billion-plus global opportunity, citing 95% lower rodent activity by month 13.
